Key result
IL-6 genetic variants are linked to inflammation and coronary artery disease risk.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
IL-6 variants may refine CAD risk models in select patients; leaves open targeted anti-inflammatory trials.
Alice Wood (2000) studied this question. Genetic variations in interleukin-6 play a central role in mediating inflammation and the associated risk of coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: